From: Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI
Patient number
Age (years)
PSA (ng/mL)
Gleason score of the dominant nodule
Pathological stage
1
59
16
7 (4 + 3)
pT3a
2
68
27
9 (5 + 4)
pT3b N0
3
10.5
4
71
10
7 (3 + 4)
pT2c
5
63
11